Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue

The expansion of GAG triplet repeats in the translated region of the human HD gene, encoding a protein (huntingtin) of unknown function, is a dominant mutation leading to manifestation of Huntington's disease. Targeted disruption of the homologous mouse gene (Hdh), to examine the normal role of huntingtin, shows that this protein is functionally indispensable, since nullizygous embryos become developmentally retarded and disorganized, and die between days 8.5 and 10.5 of gestation. Based on the observation that the level of the regionalized apoptotic cell death in the embryonic ectoderm, a layer expressing the Hdh gene, is much higher than normal in the null mutants, we propose that huntingtin is involved in processes counterbalancing the operation of an apoptotic pathway.

[1]  R. Durbin,et al.  Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.

[2]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[3]  Michael H. L. Snow,et al.  Control of Embryonic Growth Rate and Fetal Size in Mammals , 1986 .

[4]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[5]  M. Hayden,et al.  A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. , 1994, Human molecular genetics.

[6]  R. Myers,et al.  Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. , 1995, Human molecular genetics.

[7]  R. Richards,et al.  Dynamic mutations on the move. , 1993, Journal of medical genetics.

[8]  C A Ross,et al.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.

[9]  R. Albin,et al.  Genetics and molecular biology of Huntington's disease , 1995, Trends in Neurosciences.

[10]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[11]  M. Hansen,et al.  A method to isolate DNA from small archival tissue samples for p53 gene analysis , 1993, Human mutation.

[12]  Mario R. Capecchi,et al.  Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development , 1990, Nature.

[13]  D. Green,et al.  Dicing with death: dissecting the components of the apoptosis machinery. , 1994, Trends in biochemical sciences.

[14]  D. Borchelt,et al.  Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Copp,et al.  Death before birth: clues from gene knockouts and mutations. , 1995, Trends in genetics : TIG.

[16]  Leo J. Fleishman,et al.  Ultraviolet vision in lizards , 1993, Nature.

[17]  D. Harrison,et al.  Cell death in health and disease: the biology and regulation of apoptosis. , 1995, Seminars in cancer biology.

[18]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[19]  M. Capecchi,et al.  Targeted disruption of the even-skipped gene, evx1, causes early postimplantation lethality of the mouse conceptus. , 1994, Genes & development.

[20]  M. MacDonald,et al.  Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals , 1995, Annals of neurology.

[21]  A. Bradley Production and analysis of chimeric mice , 1987 .

[22]  J. Darnell,et al.  Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. , 1994, Genes & development.

[23]  G. Eguchi,et al.  Cell lineage analysis of the primitive and visceral endoderm of mouse embryos cultured in vitro. , 1987, Cell Differentiation.

[24]  E. Robertson Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[25]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[26]  F. Squitieri,et al.  Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. , 1993, Human molecular genetics.

[27]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[28]  S. Rusconi,et al.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches. , 1994, Science.

[29]  R. Roos,et al.  Characterization and localization of the Huntington disease gene product. , 1993, Human molecular genetics.

[30]  Hugh A. Carithers,et al.  Human Growth: A Comprehensive Treatise , 1987 .

[31]  S. Lewis,et al.  The developmental analysis of an embryonic lethal (C6H) in the mouse. , 1976, Journal of embryology and experimental morphology.

[32]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[33]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[34]  J. Rommens,et al.  Sequence of the murine Huntington disease gene: evidence for conservation, alternate splicing and polymorphism in a triplet (CCG) repeat [corrected]. , 1994, Human molecular genetics.

[35]  D. Steindler,et al.  DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathological Conditions , 1995, Experimental Neurology.

[36]  T. Magnuson,et al.  The albino deletion complex and early postimplantation survival in the mouse. , 1988, Development.

[37]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[38]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[39]  S. Folstein,et al.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.

[40]  T. Knudsen,et al.  Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure. , 1994, Teratology.

[41]  M. MacDonald,et al.  Mouse Huntington's disease gene homolog (Hdh) , 1994, Somatic cell and molecular genetics.

[42]  P. Leder,et al.  Murine FGFR-1 is required for early postimplantation growth and axial organization. , 1994, Genes & development.

[43]  W. Jollie Development, morphology, and function of the yolk-sac placenta of laboratory rodents. , 1990, Teratology.

[44]  H. Steller,et al.  Programmed cell death during Drosophila embryogenesis. , 1993, Development.

[45]  C. Portera-Cailliau,et al.  Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  R. Albin,et al.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.

[47]  R. Poelmann Differential mitosis and degeneration patterns in relation to the alterations in the shape of the embryonic ectoderm of early post-implantation mouse embryos. , 1980, Journal of embryology and experimental morphology.

[48]  M. Snow,et al.  Is compensatory growth a complicating factor in mouse teratology? , 1979, Nature.

[49]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[50]  Paul W Goldberg,et al.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. , 1994, The New England journal of medicine.

[51]  C. Wheeler,et al.  Sample preparation and PCR amplification from paraffin-embedded tissues. , 1994, PCR methods and applications.

[52]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[53]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[54]  E. Hirsch,et al.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.

[55]  Robert I. Richards,et al.  Dynamic mutations: A new class of mutations causing human disease , 1992, Cell.

[56]  R. Harland,et al.  In situ hybridization: an improved whole-mount method for Xenopus embryos. , 1991, Methods in cell biology.

[57]  M. Snow Growth and its control in early mammalian development. , 1981, British medical bulletin.